Article(id=1326652757550937020, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.05.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1743350400000, receivedDateStr=2025-03-31, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228265415, onlineDateStr=2026-11-09, pubDate=1746806400000, pubDateStr=2025-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228265415, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228265415, creator=13701087609, updateTime=1794228265415, updator=13701087609, issue=Issue{id=1326652739800642340, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='5', pageStart='429', pageEnd='528', issueExtLink='null', onlineDate='null', pubDate='1746806400000', pubDateStr='2025-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228261184, creator='13701087609', updateTime=1794273040769, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840559311893443, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840559311893444, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652739800642340, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=429, endPage=433, ext={EN=ArticleExt(id=1326652757873898429, articleId=1326652757550937020, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Relapse mechanisms, influencing factors, and intervention strategies of psoriasis vulgaris, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Psoriasis is a chronic, recurrent, immune-mediated systemic inflammatory skin disease that significantly impairs patients' physical and mental health as well as the quality of life of patients. With the widespread application of treatment methods such as biological agents, the therapeutic effect of psoriasis has significantly improved, but the problem of recurrence remains prominent. Immune abnormalities (such as tissue resident memory T cells, cytotoxic T cell 17), genetic susceptibility, infectious factors, environmental changes, and unhealthy lifestyles are important triggers for psoriasis recurrence. Meanwhile, there are differences in the recurrence time of different types of biologics after discontinuation, and the risk of recurrence is closely related to patient's compliance and comorbidity status. The article systematically reviewed the relevant mechanisms, influencing factors, and intervention strategies for psoriasis vulgaris recurrence, and proposed multidimensional prevention and intervention strategies for recurrence issues, including optimizing biological agent management, combination therapy regimens, improving lifestyle, and long-term follow-up mechanisms, providing reference for clinical treatment.

, authors=Lihong CHEN1, Yan QIANG2, *, authorsList=Lihong CHEN, Yan QIANG, authorCompany=null, correspAuthors=Yan QIANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652758150722494, articleId=1326652757550937020, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=寻常型银屑病复发机制、影响因素和干预对策, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

银屑病是一种常见的慢性、复发性、免疫介导的系统性炎症性皮肤病,严重影响患者的身心健康和生活质量。随着生物制剂等治疗手段的广泛应用,银屑病的治疗效果显著提升,但复发问题仍然突出。免疫异常(如组织常驻记忆性T细胞、细胞毒性T细胞17)、遗传易感、感染因素、环境变化及不良生活方式等是银屑病复发的重要诱因。同时,不同类型生物制剂在停药后的复发时间存在差异,复发风险还与患者依从性、共病状态密切相关。该文系统回顾寻常型银屑病复发的相关机制、影响因素及干预策略,并针对复发问题提出多维度预防及干预策略,包括优化生物制剂管理、联合用药方案、改善生活方式及长期随访机制,为临床治疗提供参考。

, authors=陈利红1, 强燕2, *, authorsList=陈利红, 强燕, authorCompany=null, correspAuthors=强燕, authorNote=

陈利红,副主任医师,研究方向:炎症性皮肤病。

, correspAuthorsNote=
强燕,副主任医师,研究方向:中西医结合治疗性病、皮肤肿瘤。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=YAn5noZxD0oJQpr0UufFmQ==, magXml=gLGwekaRCdOw3+VKBEttuA==, pdfUrl=null, pdf=ZNcxyzha/EeyefGpQuoeEQ==, pdfFileSize=923940, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=CjKiXu/XfBxmSr2zDD603g==, mapNumber=null, fund=null)}, authors=[Author(id=1326652760281428934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652760394675144, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760281428934, language=EN, stringName=Lihong CHEN, firstName=Lihong, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Dermatology and Sexually Transmitted Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652760495338441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760281428934, language=CN, stringName=陈利红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海交通大学医学院附属瑞金医院皮肤性病科,上海 200020, bio={"content":"

陈利红,副主任医师,研究方向:炎症性皮肤病。

"}, bioImg=null, bioContent=

陈利红,副主任医师,研究方向:炎症性皮肤病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652758440129471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, xref=1., ext=[AuthorCompanyExt(id=1326652758456906688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758440129471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Dermatology and Sexually Transmitted Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China), AuthorCompanyExt(id=1326652758477878209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758440129471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院皮肤性病科,上海 200020)])]), Author(id=1326652760642139083, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652760755385293, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760642139083, language=EN, stringName=Yan QIANG, firstName=Yan, middleName=null, lastName=QIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Medical Cosmetology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200050, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652760839271374, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760642139083, language=CN, stringName=强燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.同济大学附属皮肤病医院医学美容科,上海 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652758578541506, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, xref=2., ext=[AuthorCompanyExt(id=1326652758582735811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758578541506, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Medical Cosmetology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200050, China), AuthorCompanyExt(id=1326652758591124420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758578541506, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属皮肤病医院医学美容科,上海 200050)])])], keywords=[Keyword(id=1326652760927351759, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=EN, orderNo=1, keyword=psoriasis), Keyword(id=1326652760986072016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=EN, orderNo=2, keyword=relapse mechanism), Keyword(id=1326652761040597969, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=EN, orderNo=3, keyword=influencing factors), Keyword(id=1326652761107706834, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=EN, orderNo=4, keyword=biologics), Keyword(id=1326652761208370131, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=EN, orderNo=5, keyword=intervention strategy), Keyword(id=1326652761271284692, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=CN, orderNo=1, keyword=银屑病), Keyword(id=1326652761384530901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=CN, orderNo=2, keyword=复发机制), Keyword(id=1326652761472611286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=CN, orderNo=3, keyword=影响因素), Keyword(id=1326652761564885975, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=CN, orderNo=4, keyword=生物制剂), Keyword(id=1326652761644577752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, language=CN, orderNo=5, keyword=干预策略)], refs=[Reference(id=1326652761762018265, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南(2023版)[J]. 中华皮肤科杂志, 2023, 56(7):573-625., articleTitle=null, refAbstract=null), Reference(id=1326652761820738522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=TIAN DN, LAI YP. The relapse of psoriasis: mechanisms and mysteries[J]. JID Innov, 2022, 2(3): 100116., articleTitle=null, refAbstract=null), Reference(id=1326652761933984731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=王文秋, 王睿, 李承新. 银屑病复发的免疫学研究进展[J].中国麻风皮肤病杂志, 2023, 39(11): 845-850., articleTitle=null, refAbstract=null), Reference(id=1326652762068202460, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=张颖, 郭金竹, 张春雷. 组织常驻记忆性T细胞与银屑病复发的研究进展[J]. 中国麻风皮肤病杂志, 2022, 38(7): 493-498., articleTitle=null, refAbstract=null), Reference(id=1326652762131117021, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=胡星辛, 王秋月, 罗倩, 等. Tc17细胞在银屑病发病及复发机制中的进展[J]. 中国免疫学杂志, 2021, 37(12): 1521-1525., articleTitle=null, refAbstract=null), Reference(id=1326652762198225886, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=TAKESHITA J, GREWAL S, LANGAN SM, et al. Psoriasis and comorbid diseases: epidemiology[J]. J Am Acad Dermatol, 2017, 76(3): 377-390., articleTitle=null, refAbstract=null), Reference(id=1326652762286306271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=刘晓涵, 晋红中. 银屑病复发的危险因素及机制[J]. 协和医学杂志, 2022, 13(2): 308-314., articleTitle=null, refAbstract=null), Reference(id=1326652762353415136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=楼燕凤, 周小伟, 刘芳, 等. 寻常型银屑病复发相关因素分析及自我管理干预研究[J]. 中国麻风皮肤病杂志, 2021,37(6): 376-379., articleTitle=null, refAbstract=null), Reference(id=1326652762412135393, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=徐嵩淼, 步怀恩, 黄武, 等. 银屑病患者的复发情况及影响因素分析[J]. 中国初级卫生保健, 2021, 35(10): 71-73., articleTitle=null, refAbstract=null), Reference(id=1326652762483438562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=符文好, 刘军麟, 肖传柳, 等. 影响寻常型银屑病预后复发的危险因素调查分析[J]. 中国卫生统计, 2016, 33(5): 806-808., articleTitle=null, refAbstract=null), Reference(id=1326652762613461987, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=PATTISON E, HARRISON BJ, GRIFFITHS CE, et al.Environmental risk factors for the development of psoriatic arthritis: results from a case-control study[J]. Ann Rheum Dis, 2008, 67(5): 672-676., articleTitle=null, refAbstract=null), Reference(id=1326652762688959460, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU SH, YAO ZR. Roles of infection in psoriasis[J]. Int J Mol Sci, 2022, 23(13): 6955., articleTitle=null, refAbstract=null), Reference(id=1326652762743485413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU SW, HE MW, JIANG J, et al. Triggers for the onset and recurrence of psoriasis: a review and update[J]. Cell Commun Signal, 2024, 22(1): 108., articleTitle=null, refAbstract=null), Reference(id=1326652762823177190, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=邓琪, 毛一斌, 项彤, 等. 司库奇尤单抗治疗成人中重度斑块状银屑病的效果及复发的相关因素分析[J]. 现代实用医学, 2024, 36(2): 209-211., articleTitle=null, refAbstract=null), Reference(id=1326652762907063271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=郭金竹, 张芊, 王文慧. 古塞奇尤单抗治疗中重度斑块型银屑病的减停药复发及重启治疗模式观察[J]. 中国皮肤性病学杂志, 2024, 38(3): 271-278., articleTitle=null, refAbstract=null), Reference(id=1326652763028698088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=OWCZAREK W, DZIK M, NARBUTT J, et al. Real-world evidence on time to relapse of plaque psoriasis after discontinuation of biologic treatment in Poland[J]. Dermatol Ther, 2021, 34(5): e15052., articleTitle=null, refAbstract=null), Reference(id=1326652763162915817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG XY, ZHANG CL, WANG WH. Time to relapse after treatment withdrawal for different biologics used to treat plaque psoriasis[J]. Chin Med J(Engl), 2020, 133(24):2998-3000., articleTitle=null, refAbstract=null), Reference(id=1326652764786111466, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ALESSANDRO G, MARINA P, LUCA B, et al. Efficacy and safety of infliximab in long-term treatment of plaque-type psoriasis: A comparative retrospective study on two different(continuous vs. relapse related) regimens[J]. J Am Acade Dermatol, 2007, 56(2): AB190., articleTitle=null, refAbstract=null), Reference(id=1326652764890969067, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=GRIFFITHS CEM, STROBER BE, VAN DE KERKHOF P, et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis[J]. N Engl J Med, 2010, 362(2): 118-128., articleTitle=null, refAbstract=null), Reference(id=1326652764966466540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ORTONNE JP, TAIEB A, ORMEROD AD, et al. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept[J]. Br J Dermatol, 2009,161(5): 1190-1195., articleTitle=null, refAbstract=null), Reference(id=1326652765029381101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=PAPP K, CROWLEY J, ORTONNE JP, et al. Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy[J]. Br J Dermatol, 2011, 164(2):434-441., articleTitle=null, refAbstract=null), Reference(id=1326652765134238702, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=REICH K, ORTONNE JP, GOTTLIEB AB, et al. Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase Ⅱrandomized, placebo-controlled trial with a re-treatment extension[J]. Br J Dermatol, 2012, 167(1): 180-190., articleTitle=null, refAbstract=null), Reference(id=1326652765239096303, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=MROWIETZ U, LEONARDI CL, GIROLOMONI G,et al. Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: a randomized, double-blind, noninferiority trial(SCULPTURE)[J]. J Am Acad Dermatol, 2015, 73(1):27-36., articleTitle=null, refAbstract=null), Reference(id=1326652765415257072, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=BLAUVELT A, PAPP KA, SOFEN H, et al. Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis[J]. J Eur Acad Dermatol Venereol, 2017, 31(6): 1004-1013., articleTitle=null, refAbstract=null), Reference(id=1326652765574640625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=REGNAULT MM, KONSTANTINOU MP, KHEMIS A,et al. Early relapse of psoriasis after stopping brodalumab:a retrospective cohort study in 77 patients[J]. J Eur Acad Dermatol Venereol, 2017, 31(9): 1491-1496., articleTitle=null, refAbstract=null), Reference(id=1326652765679498226, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=KIMBALL AB, PAPP KA, REICH K, et al. Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase Ⅲ studies[J].Br J Dermatol, 2020, 182(6): 1359-1368., articleTitle=null, refAbstract=null), Reference(id=1326652765876630515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=RIVERA R, MARTORELL A, LOPEZ A, et al. Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study[J]. J Eur Acad Dermatol Venereol, 2021,35(1): e65-e67., articleTitle=null, refAbstract=null), Reference(id=1326652765994071028, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=BLAUVELT A, LEONARDI CL, GOODERHAM M, et al.Efficacy and safety of continuous risankizumab therapy vs treatment withdrawal in patients with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial[J]. J Am Med Assoc Dermatol, 2020, 156(6): 649-658., articleTitle=null, refAbstract=null), Reference(id=1326652766086345717, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=REGNAULT MM, SHOURICK J, JENDOUBI F, et al. Time to relapse after discontinuing systemic treatment for psoriasis:a systematic review[J]. Am J Clin Dermatol, 2022, 23(4):433-447., articleTitle=null, refAbstract=null), Reference(id=1326652766174426102, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=孔宇虹. 如何预防银屑病的复发[J]. 家庭医学, 2023, (8):22-23., articleTitle=null, refAbstract=null), Reference(id=1326652766283478007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会皮肤性病学分会银屑病专业委员会. 银屑病生物制剂达标治疗专家共识[J]. 中华皮肤科杂志, 2023,56(3): 191-203., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1326652758440129471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, xref=1., ext=[AuthorCompanyExt(id=1326652758456906688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758440129471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Dermatology and Sexually Transmitted Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China), AuthorCompanyExt(id=1326652758477878209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758440129471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院皮肤性病科,上海 200020)]), AuthorCompany(id=1326652758578541506, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, xref=2., ext=[AuthorCompanyExt(id=1326652758582735811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758578541506, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Medical Cosmetology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200050, China), AuthorCompanyExt(id=1326652758591124420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758578541506, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属皮肤病医院医学美容科,上海 200050)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.05.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.05.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.05.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.05.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1746806400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
寻常型银屑病复发机制、影响因素和干预对策
陈利红 1 , 强燕 2, *
世界临床药物 | 医药专论 2025,46(5): 429-433
收起
收藏切换
世界临床药物 |医药专论 2025 , 46 (5) : 429 -433
寻常型银屑病复发机制、影响因素和干预对策
全屏
[Author(id=1326652760281428934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652760394675144, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760281428934, language=EN, stringName=Lihong CHEN, firstName=Lihong, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Dermatology and Sexually Transmitted Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652760495338441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760281428934, language=CN, stringName=陈利红, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海交通大学医学院附属瑞金医院皮肤性病科,上海 200020, bio={"content":"

陈利红,副主任医师,研究方向:炎症性皮肤病。

"}, bioImg=null, bioContent=

陈利红,副主任医师,研究方向:炎症性皮肤病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652758440129471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, xref=1., ext=[AuthorCompanyExt(id=1326652758456906688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758440129471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Dermatology and Sexually Transmitted Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China), AuthorCompanyExt(id=1326652758477878209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758440129471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海交通大学医学院附属瑞金医院皮肤性病科,上海 200020)])]), Author(id=1326652760642139083, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652760755385293, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760642139083, language=EN, stringName=Yan QIANG, firstName=Yan, middleName=null, lastName=QIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Medical Cosmetology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200050, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652760839271374, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, authorId=1326652760642139083, language=CN, stringName=强燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.同济大学附属皮肤病医院医学美容科,上海 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652758578541506, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, xref=2., ext=[AuthorCompanyExt(id=1326652758582735811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758578541506, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Medical Cosmetology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200050, China), AuthorCompanyExt(id=1326652758591124420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652757550937020, companyId=1326652758578541506, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属皮肤病医院医学美容科,上海 200050)])])]
陈利红1, 强燕2, *
作者信息
  • 1.上海交通大学医学院附属瑞金医院皮肤性病科,上海 200020
  • 2.同济大学附属皮肤病医院医学美容科,上海 200050
通讯作者:
强燕,副主任医师,研究方向:中西医结合治疗性病、皮肤肿瘤。
作者简介:

陈利红,副主任医师,研究方向:炎症性皮肤病。

Relapse mechanisms, influencing factors, and intervention strategies of psoriasis vulgaris
Lihong CHEN1, Yan QIANG2, *
Affiliations
  • 1.Department of Dermatology and Sexually Transmitted Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China
  • 2.Department of Medical Cosmetology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200050, China
出版时间: 2025-05-10 doi: 10.13683/j.wph.2025.05.001
文章导航
收藏切换

银屑病是一种常见的慢性、复发性、免疫介导的系统性炎症性皮肤病,严重影响患者的身心健康和生活质量。随着生物制剂等治疗手段的广泛应用,银屑病的治疗效果显著提升,但复发问题仍然突出。免疫异常(如组织常驻记忆性T细胞、细胞毒性T细胞17)、遗传易感、感染因素、环境变化及不良生活方式等是银屑病复发的重要诱因。同时,不同类型生物制剂在停药后的复发时间存在差异,复发风险还与患者依从性、共病状态密切相关。该文系统回顾寻常型银屑病复发的相关机制、影响因素及干预策略,并针对复发问题提出多维度预防及干预策略,包括优化生物制剂管理、联合用药方案、改善生活方式及长期随访机制,为临床治疗提供参考。

银屑病  /  复发机制  /  影响因素  /  生物制剂  /  干预策略

Psoriasis is a chronic, recurrent, immune-mediated systemic inflammatory skin disease that significantly impairs patients' physical and mental health as well as the quality of life of patients. With the widespread application of treatment methods such as biological agents, the therapeutic effect of psoriasis has significantly improved, but the problem of recurrence remains prominent. Immune abnormalities (such as tissue resident memory T cells, cytotoxic T cell 17), genetic susceptibility, infectious factors, environmental changes, and unhealthy lifestyles are important triggers for psoriasis recurrence. Meanwhile, there are differences in the recurrence time of different types of biologics after discontinuation, and the risk of recurrence is closely related to patient's compliance and comorbidity status. The article systematically reviewed the relevant mechanisms, influencing factors, and intervention strategies for psoriasis vulgaris recurrence, and proposed multidimensional prevention and intervention strategies for recurrence issues, including optimizing biological agent management, combination therapy regimens, improving lifestyle, and long-term follow-up mechanisms, providing reference for clinical treatment.

psoriasis  /  relapse mechanism  /  influencing factors  /  biologics  /  intervention strategy
陈利红, 强燕. 寻常型银屑病复发机制、影响因素和干预对策. 世界临床药物, 2025 , 46 (5) : 429 -433 . DOI: 10.13683/j.wph.2025.05.001
Lihong CHEN, Yan QIANG. Relapse mechanisms, influencing factors, and intervention strategies of psoriasis vulgaris[J]. World Clinical Drug, 2025 , 46 (5) : 429 -433 . DOI: 10.13683/j.wph.2025.05.001

参考文献 引证文献
排序方式:
[1]
中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南(2023版)[J]. 中华皮肤科杂志, 2023, 56(7):573-625.
[2]
TIAN DN, LAI YP. The relapse of psoriasis: mechanisms and mysteries[J]. JID Innov, 2022, 2(3): 100116.
[3]
王文秋, 王睿, 李承新. 银屑病复发的免疫学研究进展[J].中国麻风皮肤病杂志, 2023, 39(11): 845-850.
[4]
张颖, 郭金竹, 张春雷. 组织常驻记忆性T细胞与银屑病复发的研究进展[J]. 中国麻风皮肤病杂志, 2022, 38(7): 493-498.
[5]
胡星辛, 王秋月, 罗倩, 等. Tc17细胞在银屑病发病及复发机制中的进展[J]. 中国免疫学杂志, 2021, 37(12): 1521-1525.
[6]
TAKESHITA J, GREWAL S, LANGAN SM, et al. Psoriasis and comorbid diseases: epidemiology[J]. J Am Acad Dermatol, 2017, 76(3): 377-390.
[7]
刘晓涵, 晋红中. 银屑病复发的危险因素及机制[J]. 协和医学杂志, 2022, 13(2): 308-314.
[8]
楼燕凤, 周小伟, 刘芳, 等. 寻常型银屑病复发相关因素分析及自我管理干预研究[J]. 中国麻风皮肤病杂志, 2021,37(6): 376-379.
[9]
徐嵩淼, 步怀恩, 黄武, 等. 银屑病患者的复发情况及影响因素分析[J]. 中国初级卫生保健, 2021, 35(10): 71-73.
[10]
符文好, 刘军麟, 肖传柳, 等. 影响寻常型银屑病预后复发的危险因素调查分析[J]. 中国卫生统计, 2016, 33(5): 806-808.
[11]
PATTISON E, HARRISON BJ, GRIFFITHS CE, et al.Environmental risk factors for the development of psoriatic arthritis: results from a case-control study[J]. Ann Rheum Dis, 2008, 67(5): 672-676.
[12]
ZHOU SH, YAO ZR. Roles of infection in psoriasis[J]. Int J Mol Sci, 2022, 23(13): 6955.
[13]
LIU SW, HE MW, JIANG J, et al. Triggers for the onset and recurrence of psoriasis: a review and update[J]. Cell Commun Signal, 2024, 22(1): 108.
[14]
邓琪, 毛一斌, 项彤, 等. 司库奇尤单抗治疗成人中重度斑块状银屑病的效果及复发的相关因素分析[J]. 现代实用医学, 2024, 36(2): 209-211.
[15]
郭金竹, 张芊, 王文慧. 古塞奇尤单抗治疗中重度斑块型银屑病的减停药复发及重启治疗模式观察[J]. 中国皮肤性病学杂志, 2024, 38(3): 271-278.
[16]
OWCZAREK W, DZIK M, NARBUTT J, et al. Real-world evidence on time to relapse of plaque psoriasis after discontinuation of biologic treatment in Poland[J]. Dermatol Ther, 2021, 34(5): e15052.
[17]
WANG XY, ZHANG CL, WANG WH. Time to relapse after treatment withdrawal for different biologics used to treat plaque psoriasis[J]. Chin Med J(Engl), 2020, 133(24):2998-3000.
[18]
ALESSANDRO G, MARINA P, LUCA B, et al. Efficacy and safety of infliximab in long-term treatment of plaque-type psoriasis: A comparative retrospective study on two different(continuous vs. relapse related) regimens[J]. J Am Acade Dermatol, 2007, 56(2): AB190.
[19]
GRIFFITHS CEM, STROBER BE, VAN DE KERKHOF P, et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis[J]. N Engl J Med, 2010, 362(2): 118-128.
[20]
ORTONNE JP, TAIEB A, ORMEROD AD, et al. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept[J]. Br J Dermatol, 2009,161(5): 1190-1195.
[21]
PAPP K, CROWLEY J, ORTONNE JP, et al. Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy[J]. Br J Dermatol, 2011, 164(2):434-441.
[22]
REICH K, ORTONNE JP, GOTTLIEB AB, et al. Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase Ⅱrandomized, placebo-controlled trial with a re-treatment extension[J]. Br J Dermatol, 2012, 167(1): 180-190.
[23]
MROWIETZ U, LEONARDI CL, GIROLOMONI G,et al. Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: a randomized, double-blind, noninferiority trial(SCULPTURE)[J]. J Am Acad Dermatol, 2015, 73(1):27-36.
[24]
BLAUVELT A, PAPP KA, SOFEN H, et al. Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis[J]. J Eur Acad Dermatol Venereol, 2017, 31(6): 1004-1013.
[25]
REGNAULT MM, KONSTANTINOU MP, KHEMIS A,et al. Early relapse of psoriasis after stopping brodalumab:a retrospective cohort study in 77 patients[J]. J Eur Acad Dermatol Venereol, 2017, 31(9): 1491-1496.
[26]
KIMBALL AB, PAPP KA, REICH K, et al. Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase Ⅲ studies[J].Br J Dermatol, 2020, 182(6): 1359-1368.
[27]
RIVERA R, MARTORELL A, LOPEZ A, et al. Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study[J]. J Eur Acad Dermatol Venereol, 2021,35(1): e65-e67.
[28]
BLAUVELT A, LEONARDI CL, GOODERHAM M, et al.Efficacy and safety of continuous risankizumab therapy vs treatment withdrawal in patients with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial[J]. J Am Med Assoc Dermatol, 2020, 156(6): 649-658.
[29]
REGNAULT MM, SHOURICK J, JENDOUBI F, et al. Time to relapse after discontinuing systemic treatment for psoriasis:a systematic review[J]. Am J Clin Dermatol, 2022, 23(4):433-447.
[30]
孔宇虹. 如何预防银屑病的复发[J]. 家庭医学, 2023, (8):22-23.
[31]
中华医学会皮肤性病学分会银屑病专业委员会. 银屑病生物制剂达标治疗专家共识[J]. 中华皮肤科杂志, 2023,56(3): 191-203.
2025年第46卷第5期
50
14
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.05.001
  • 接收时间:2025-03-31
  • 首发时间:2026-11-09
  • 出版时间:2025-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-03-31
基金
作者信息
    1.上海交通大学医学院附属瑞金医院皮肤性病科,上海 200020
    2.同济大学附属皮肤病医院医学美容科,上海 200050

通讯作者:

强燕,副主任医师,研究方向:中西医结合治疗性病、皮肤肿瘤。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.05.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏